This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of cervix uteri, exocervix
CD2_INSITU_CERVIX_UTERI_EXOCERVIX_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D06
- Name in latin
- Carcinoma in situ exocervicis (uteri)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of cervix uteri, exocervix
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of cervix uteri, exocervix
- HSIL lesion of the cervix uteri
- HSIL lesion of the cervix uteri, vagina or vulva
- All dysplastic lesions of the cervix uteri
- All dysplastic lesions of the cervix uteri, vagina or vulva
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 259 | 259 | - |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | - |
| Median age at first event (years) | 35.48 | 35.48 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 243
- Matched controls
- 2429
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
+∞
323.0
243
*
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
498.0
119.6
110
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
35.6
105.2
144
95
ULA02
NOMESCO Finland
Kolposcopy
24.0
100.6
175
235
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
23.7
100.0
175
238
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
287.7
65.7
64
*
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
25.7
53.9
77
43
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
12.1
53.7
111
157
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
6.8
37.1
116
287
LDA10
NOMESCO Finland
Curettage of cervix uteri
11.8
35.3
69
79
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
21.6
33.1
49
28
ZXC00
NOMESCO Finland
Use of diathermy
33.8
27.2
35
12
N87.1
ICD-10 Finland
Moderate cervical dysplasia
12.5
23.0
42
40
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
126.4
22.0
23
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.6
17.1
41
63
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
159.1
14.6
15
*
LCD10
NOMESCO Finland
Vaginal hysterectomy
7.7
13.7
32
47
H02AB02
ATC
dexamethasone; systemic
26.0
12.6
17
7
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
A04AA02
ATC
granisetron; systemic, transdermal
136.7
12.6
13
*
C539, 6666, 0
ICD-O-3
NA
17.0
12.4
19
12
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
11.5
11
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
9.4
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
9.4
9
*
8010/2-C53.9
ICD-O-3
Carcinoma in situ, NOS, of cervix uteri
+∞
9.4
9
*
G01AA10
ATC
clindamycin; vaginal
2.5
9.0
87
441
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
5.1
9.0
28
61
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.8
8.4
60
255
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
8.4
8
*
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
4.8
8.4
27
61
XX3DW
NOMESCO Finland
Time consuming IT work
6.5
8.0
20
33
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
7.3
7
*
LEB00
NOMESCO Finland
Biopsy of vagina
6.9
7.3
17
26
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.3
7.2
26
66
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
11.4
6.4
11
10
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
27
48
6.16
14.95
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
151
3.13
9.28
2.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
114
689
2.17
8.35
2.2
1.4
—
—
—
0
0
(3013512) EKG study
79
446
2.11
6.64
3.2
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
126
874
1.86
5.63
2.1
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
21
5.43
5.57
2.8
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
66
370
2.05
5.55
1.6
1.5
pmol/l
429.3
61128036.3
1.05
53
337
(3032080) INR in Blood by Coagulation assay
82
542
1.75
4.02
6.6
5.3
inr
1.1
1.1
0.19
39
176
(40761536) Microorganisms panel - Urine sediment
33
161
2.20
3.92
2.3
2.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
144
2.23
3.71
2.9
4.4
%
0.3
0.1
—
8
27
(3025159) Blasts/100 leukocytes in Blood
29
140
2.21
3.54
3.0
4.4
%
0.0
0.3
—
7
23
(3019225) pH of Specimen
30
149
2.15
3.42
2.6
3.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
30
151
2.12
3.31
2.9
4.3
%
3.3
1.0
—
8
29
(3024561) Albumin [Mass/volume] in Serum or Plasma
97
706
1.60
3.18
4.2
3.7
g/l
36.0
37.2
1.66
87
659
(3021901) Oxygen saturation in Capillary blood
9
21
4.40
3.02
3.1
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
80
564
1.61
2.96
3.9
4.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
17
70
2.53
2.94
1.2
1.4
u/l
13.7
28.7
1.55
11
55
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
195
1.92
2.94
3.4
4.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
28
144
2.06
2.93
3.0
3.9
%
5.9
0.8
—
7
21
(4281824)
7
13
5.50
2.89
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
153
2.01
2.84
2.5
2.1
u/l
782.4
2831.9
—
7
69
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
85
616
1.57
2.78
2.2
2.7
ng/l
21.9
17.8
0.20
34
284
(36660697) Celiac disease serology panel - Serum
9
219
0.39
2.44
1.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
12
5.09
2.41
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
148
1.92
2.39
2.8
2.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
82
611
1.50
2.31
2.1
2.2
u/l
52.0
56.2
0.61
76
567
(3035637) Corticotropin [Mass/volume] in Plasma
8
23
3.55
2.29
1.3
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
265
0.43
2.28
1.7
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
85
641
1.49
2.25
3.1
2.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
215
1.73
2.17
3.5
3.5
%
31.4
32.4
0.20
22
159
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
33
2.79
1.95
1.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
197
2139
0.67
1.93
7.9
10.3
%
39.2
39.9
0.45
144
1770
(3026008) Bacteria identified in Urine by Culture
70
523
1.46
1.91
2.4
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
34
2.70
1.88
4.0
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
45
307
1.56
1.88
3.5
3.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
28
2.91
1.88
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
28
2.91
1.88
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
28
2.91
1.88
1.0
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
123
1021
1.39
1.86
3.3
3.6
mmol/l
6.0
6.3
0.87
114
929
(3018010) Neutrophils/100 leukocytes in Blood
123
1022
1.39
1.84
5.5
5.6
%
55.2
56.7
0.84
117
957
(3021589) Normoblasts [#/volume] in Blood
113
931
1.38
1.76
10.5
6.8
e9/l
0.0
0.0
0.08
98
758
(1761482) Bacteria [#/volume] in Urine by Culture
9
36
2.55
1.75
4.3
2.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
71
542
1.43
1.72
1.8
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
25
150
1.74
1.71
9.4
10.5
inr
1.2
1.2
0.01
12
26
(3011397) Hemoglobin [Presence] in Urine by Test strip
30
453
0.62
1.70
4.8
3.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
183
1637
1.40
1.68
4.1
3.9
mm/h
10.9
9.2
0.74
168
1546
(3023103) Potassium [Moles/volume] in Serum or Plasma
233
2189
1.64
1.61
10.3
9.2
mmol/l
3.9
3.9
0.06
225
2132
(3013290) Carbon dioxide [Partial pressure] in Blood
7
26
2.74
1.59
4.9
2.3
kpa
5.1
4.9
—
7
26
(3027315) Oxygen [Partial pressure] in Blood
7
26
2.74
1.59
4.9
2.3
kpa
8.5
9.1
—
7
26
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
33
2.47
1.55
3.4
1.7
g/l
140.4
133.2
—
8
21
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
127
0.38
1.54
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
27
2.64
1.52
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
27
2.64
1.52
7.0
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
27
2.64
1.52
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
27
2.64
1.52
1.0
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
121
1027
1.33
1.49
5.8
5.8
%
29.3
29.9
0.32
113
957
(3037467) Urinalysis macro (dipstick) panel - Urine
166
1477
1.35
1.48
3.3
3.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
52
2.16
1.46
1.0
1.3
—
1.0
—
0
5
(3029937) Albumin [Presence] in Urine by Test strip
68
530
1.38
1.45
3.5
3.2
estimate
0.0
0.0
0.50
35
197
(3022806) Fractional oxyhemoglobin in Capillary blood
5
16
3.16
1.44
1.0
1.6
%
90.9
91.3
—
5
16
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
230
2166
1.55
1.43
3.5
3.4
mmol/l
1.3
1.2
0.75
213
2054
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
99
821
1.33
1.42
4.9
5.0
mmol/l
1.2
1.2
0.06
75
713
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
104
1.79
1.41
1.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
32
217
1.54
1.39
1.2
1.1
—
—
—
0
0
(44813793)
5
17
2.98
1.36
1.4
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
17
2.98
1.36
4.6
3.5
mu/l
32.2
17.2
—
5
17
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
68
1.96
1.36
2.2
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
38
0.00
1.35
0.0
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
128
1107
1.31
1.34
5.9
5.7
e9/l
1.9
2.0
0.31
116
991
(3037522) Nuclear Ab [Titer] in Serum
51
384
1.41
1.33
1.3
1.4
titre
1190.8
487.1
0.89
13
90
(3019550) Sodium [Moles/volume] in Serum or Plasma
231
2185
1.53
1.31
10.3
9.1
mmol/l
139.7
139.7
0.00
223
2131
(3008037) Lactate [Moles/volume] in Venous blood
6
24
2.53
1.31
1.7
2.9
mmol/l
1.3
1.3
—
6
24
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
62
1.98
1.30
2.3
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
92
1.79
1.28
1.4
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
596
1.34
1.28
3.3
1.9
mmol/l
2.4
2.3
0.42
69
534
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
100
841
1.31
1.27
3.6
2.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
86
710
1.32
1.25
3.8
4.5
mmol/l
1.2
1.2
0.24
69
653
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
25
2.43
1.25
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
63
1.95
1.25
3.2
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
116
998
1.29
1.24
6.1
6.0
%
8.0
7.7
0.30
109
935
(3009343) pH of Capillary blood
15
86
1.79
1.22
3.5
3.1
ph
7.4
7.4
—
6
12
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
408
1.38
1.22
1.9
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
115
991
1.29
1.21
5.9
5.7
%
2.8
2.8
0.10
107
923
(3050129) First trimester maternal screen panel - Serum or Plasma
6
129
0.45
1.20
2.2
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
49
374
1.38
1.18
1.5
1.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
124
1081
1.28
1.18
6.0
5.7
e9/l
0.0
0.0
0.38
112
946
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
178
1625
1.30
1.18
3.0
2.8
u/l
59.3
35.5
0.67
167
1565
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
887
1.29
1.18
3.5
3.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
30
2.37
1.13
1.4
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
21
2.41
1.09
1.0
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
52
408
1.34
1.06
1.4
1.4
nmol/l
20.3
23.0
0.78
47
358
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
169
1544
1.27
1.05
8.1
5.0
u/l
71.7
72.6
0.14
162
1441
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
172
1.50
1.04
1.6
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
147
1.54
1.04
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
362
0.69
1.02
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
204
1912
1.32
1.01
4.9
4.5
pmol/l
14.2
14.2
0.10
192
1829
(3012544) pH of Venous blood
17
108
1.61
0.99
1.5
3.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
23
2.20
0.98
1.8
3.0
mmol/l
5.9
7.5
—
5
23
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
234
2244
1.44
0.95
3.8
3.7
mmol/l
1.5
1.6
0.34
221
2140
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
37
1.92
0.94
1.4
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
235
2256
1.45
0.94
3.8
3.8
mmol/l
4.9
4.9
0.20
222
2165
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
1173
1.24
0.93
10.7
7.0
e9/l
3.9
4.0
0.45
120
1019
(3013115) Eosinophils [#/volume] in Blood
126
1125
1.23
0.91
6.1
6.1
e9/l
0.2
0.2
0.21
114
1008
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
365
0.71
0.91
1.3
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
105
921
1.24
0.89
2.3
2.3
nmol/l
75.4
75.2
0.03
97
855
(3009261) Glucose [Presence] in Urine by Test strip
120
1068
1.23
0.89
3.8
3.0
estimate
0.0
0.0
0.80
37
193
(3007164) IgA [Mass/volume] in Serum or Plasma
41
515
0.76
0.86
1.4
1.3
g/l
2.0
2.2
0.33
32
325
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
139
0.56
0.86
1.5
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
140
0.56
0.85
1.5
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
45
1.80
0.85
1.1
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
200
0.63
0.83
1.3
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
42
332
1.32
0.83
2.5
2.3
ug/g
195.0
88.6
0.64
34
267
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
228
2187
1.36
0.83
5.4
5.1
mu/l
1.8
2.3
0.47
210
2089
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
33
1.84
0.79
1.2
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
1.5
—
497.1
—
0
21
(40758558) Short blood count panel - Blood
38
475
0.77
0.78
7.5
5.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
43
345
1.30
0.77
2.0
2.2
e6/l
6.8
9.8
0.46
38
305
(3002582) Erythrocytes [#/volume] in Urine
59
493
1.25
0.77
2.3
2.6
e6/l
274.8
77.6
0.33
46
364
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
47
569
0.79
0.75
1.6
1.6
mmol/l
1.5
1.4
0.16
38
504
(40760888) Immunoglobulin light chains.free panel - Serum
5
24
2.10
0.75
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
18
125
1.47
0.75
1.1
1.3
—
1.0
—
0
11
(3001604) Monocytes [#/volume] in Blood
119
1075
1.20
0.72
6.2
5.6
e9/l
0.5
0.5
0.03
109
946
(3021601) Nitrite [Presence] in Urine by Test strip
117
1059
1.19
0.69
5.1
4.2
estimate
0.0
0.0
0.50
37
196
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
6.0
2.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
27
1.87
0.69
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
235
2276
1.35
0.68
3.9
4.1
mmol/l
2.9
3.0
0.36
222
2166
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
228
2202
1.30
0.65
11.2
9.1
mg/l
18.2
17.3
0.16
180
1638
(3008898) HLA-B27 [Presence]
10
153
0.64
0.65
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
50
419
1.24
0.64
1.7
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
15
104
1.47
0.64
1.6
3.5
mmol/l
3.6
1.9
—
9
80
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
243
2369
1.42
0.63
10.4
7.7
u/l
23.0
23.7
0.40
235
2312
(1002224) Polysomnography panel
9
140
0.63
0.62
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
28
220
1.31
0.60
1.4
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
54
1.50
0.58
1.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
500
1.21
0.58
1.2
1.3
iu/ml
42.1
31.7
0.25
11
177
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
261
0.75
0.57
1.4
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
105
955
1.17
0.56
6.3
5.8
%
0.7
0.7
0.23
99
882
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
182
0.70
0.56
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
159
0.68
0.56
1.2
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
68
598
1.19
0.55
2.9
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
38
315
1.24
0.55
1.8
1.6
%
1.3
1.3
0.21
31
289
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
38
1.59
0.54
4.0
1.8
nmol/l
1.3
0.9
—
6
33
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
55
480
1.19
0.48
2.1
2.1
mg/l
2.8
2.7
0.19
48
412
(40768443) Skin Pathology biopsy report
10
68
1.49
0.47
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
58
510
1.18
0.47
1.2
1.3
u/ml
2.1
13.0
3.39
24
225
(3016879) Cocaine [Presence] in Urine
14
103
1.38
0.46
1.5
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
9
126
0.70
0.44
2.9
3.6
ng/l
61.0
73.8
—
9
117
(3030467) Casts [#/volume] in Urine by Automated count
51
446
1.18
0.44
2.2
2.4
e6/l
0.4
0.3
0.14
38
320
(3011288) Drugs identified in Urine by Screen method
11
78
1.43
0.44
1.5
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
13
96
1.37
0.42
2.9
2.3
u/l
36.4
40.0
0.36
13
89
(40768793) Breast Pathology biopsy report
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
194
0.76
0.42
1.3
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.4
—
1.9
—
0
17
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
333
0.82
0.40
1.5
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
18
0.00
0.40
0.0
1.9
—
58.7
—
0
18
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
71
1.42
0.40
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
35
1.44
0.39
1.6
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
59
528
1.15
0.39
2.2
2.9
mmol/l
7.7
7.4
0.17
49
451
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
89
1.37
0.38
1.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
36
1.40
0.38
1.2
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
107
1.33
0.38
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
115
0.69
0.38
1.1
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
18
223
0.79
0.37
1.7
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
72
1.40
0.37
4.5
5.2
mmol/l
25.8
24.6
—
10
72
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
319
0.83
0.37
1.3
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
53
473
1.15
0.36
1.5
2.1
umol/l
309.1
5231.2
2.07
45
435
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
37
321
1.18
0.36
2.2
2.7
ng/l
1240.1
450.5
0.58
24
262
(3007461) Platelets [#/volume] in Blood
254
2512
1.58
0.36
17.4
14.0
e9/l
270.3
269.7
0.06
249
2468
(3028300) Cannabinoids [Presence] in Urine
14
108
1.31
0.36
1.5
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
108
1.31
0.36
1.5
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
9
124
0.72
0.36
3.1
6.7
kpa
14.4
12.3
—
9
118
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
9
124
0.72
0.36
3.1
6.7
kpa
5.0
5.2
—
9
118
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
42
1.44
0.36
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
43
1.40
0.35
2.7
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
453
0.86
0.34
1.4
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
100
1.32
0.34
1.2
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
220
2148
1.16
0.34
4.1
3.7
mmol/l
5.6
5.7
0.70
208
2034
(3000991) Gas panel - Venous blood
6
87
0.68
0.33
2.7
6.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
316
1.16
0.31
1.4
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
104
978
1.11
0.31
2.7
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
53
1.33
0.31
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
185
0.80
0.31
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
127
1208
1.10
0.30
2.6
2.9
ug/l
84.1
65.4
1.28
117
1146
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
110
0.72
0.29
1.4
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
57
1.23
0.29
1.7
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
239
2353
1.20
0.29
12.8
9.4
umol/l
67.2
66.5
0.23
239
2353
(3035350) Ketones [Presence] in Urine by Test strip
112
1061
1.10
0.28
3.7
3.0
estimate
0.0
0.0
0.00
36
195
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
66
1.22
0.27
1.6
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
52
475
1.12
0.26
3.2
3.7
mg/mmol
1.6
5.5
1.76
32
286
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
10
77
1.31
0.26
2.3
1.6
—
0.0
—
0
8
(3000330) Specific gravity of Urine by Test strip
10
77
1.31
0.26
5.5
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
73
0.68
0.26
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
31
275
1.14
0.24
1.9
1.6
nmol/l
1384.2
1138.5
0.70
24
216
(3020891) Body temperature
5
38
1.32
0.23
2.8
4.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
157
0.82
0.23
1.2
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
52
480
1.10
0.22
4.1
3.0
ph
7.4
7.4
0.20
20
73
(3027944) Amphetamines [Presence] in Urine
13
107
1.23
0.22
1.5
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
55
592
0.91
0.22
1.5
1.6
—
—
—
0
0
(4010399)
16
135
1.20
0.22
1.3
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
70
657
1.09
0.21
2.8
3.0
e6/l
77.1
35.5
0.41
52
408
(3024263) Appearance of Synovial fluid
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
10
0.00
0.21
0.0
5.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
1.8
—
10.5
—
0
10
(3036071) Salmonella sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
12
0.00
0.21
0.0
2.8
—
12.5
—
0
7
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
13
0.00
0.21
0.0
2.9
—
17.2
—
0
13
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.3
—
8.3
—
0
14
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
49
1.23
0.20
1.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
203
1991
1.09
0.20
4.8
4.5
mmol/mol
37.1
38.1
1.48
191
1900
(36304419) Bacteria [Presence] in Urine
49
455
1.09
0.19
2.0
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
69
651
1.08
0.19
6.5
5.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
59
1.19
0.18
4.0
2.8
mg/l
7.7
9.5
—
7
53
(3022313) Gas panel - Capillary blood
7
60
1.17
0.18
3.4
3.2
—
—
—
0
0
(3015736) pH of Urine
87
833
1.07
0.16
3.5
2.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
90
0.77
0.14
1.6
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
132
1.14
0.13
3.5
3.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
94
1.18
0.13
2.0
2.3
—
—
—
0
0
(3044889) 12 lead EKG panel
145
1417
1.05
0.13
2.8
2.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
76
730
1.06
0.13
1.7
1.8
pmol/l
93.2
98.3
0.52
50
389
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
292
0.92
0.12
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
48
455
1.07
0.12
2.3
3.1
mg/l
8.0
353.1
0.88
32
280
(3007853) Bacteria identified in Skin by Aerobe culture
23
211
1.10
0.11
2.0
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
31
289
1.08
0.11
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
184
1867
0.95
0.11
3.5
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
23
248
0.92
0.10
1.6
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
223
1.08
0.09
1.8
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
52
499
1.05
0.09
1.5
1.7
mg/l
1.0
0.7
0.40
42
379
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
55
1.09
0.09
2.2
2.3
%
153.3
155.0
—
6
55
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
58
1.04
0.08
1.0
1.2
mmol/l
3.5
3.7
—
6
53
(3007566) Smooth muscle Ab [Titer] in Serum
5
61
0.82
0.08
1.2
1.1
—
70.0
—
0
7
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
63
0.79
0.08
2.0
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
65
0.76
0.08
1.2
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
56
540
1.05
0.08
1.9
1.9
u/l
136.6
108.8
0.22
50
521
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
75
0.80
0.07
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
76
1.05
0.07
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
119
1.10
0.06
3.0
2.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
90
1.12
0.05
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
54
555
0.97
0.05
1.5
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
45
464
0.96
0.05
3.4
3.1
kg/l
1.0
1.0
—
5
61
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
210
2087
1.03
0.04
11.0
7.2
ml/min/173m2
88.6
89.2
0.17
180
1672
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
608
1.03
0.03
1.2
1.3
u/ml
0.6
2.0
1.19
30
179
(3042936) Bacteria identified in Isolate by Culture
20
209
0.95
0.03
1.5
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
64
630
1.02
0.02
1.5
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
237
0.97
0.01
2.4
2.2
e6/l
2.6
4.5
0.89
11
110
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
30
307
0.97
0.01
2.7
3.0
ng/l
18.7
389.7
0.79
12
173
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
74
734
1.01
0.00
3.3
2.7
u/l
31.8
27.4
0.56
67
708
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
19
191
0.99
0.00
4.5
3.5
pmol/l
4.6
4.6
0.03
19
169
(40761511) CBC panel - Blood by Automated count
237
2371
1.00
0.00
11.1
8.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
269
1.00
0.00
1.3
1.2
iu/ml
187.7
148.4
0.19
11
121
(3027945) Reticulocytes/100 erythrocytes in Blood
13
127
1.02
0.00
1.7
2.8
%
1.2
1.6
—
8
110
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
254
0.98
0.00
2.3
2.0
e6/l
0.5
1.1
1.59
12
128
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
5.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.5
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
1.2
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
1.2
—
197.7
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
69.9
—
0
9
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
5
0.00
0.00
0.0
1.2
—
367.6
—
0
5
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
2285.9
—
0
8
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
91
0.99
0.00
2.7
2.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
6
64
0.94
0.00
3.7
7.8
%
95.1
94.1
—
6
64
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
97
0.93
0.00
1.6
1.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
230
1.00
0.00
1.4
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.2
—
0
6
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
52
0.96
0.00
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
2.3
—
57.5
—
0
6
(3034770) Mitochondria Ab [Titer] in Serum
5
56
0.89
0.00
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
66
0.91
0.00
3.7
7.5
%
0.9
0.6
—
6
66
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
49
1.02
0.00
1.4
1.0
—
0.2
—
0
10
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
57
0.87
0.00
3.2
6.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.4
—
0
6
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
59
1.02
0.00
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
17.4
—
0
6
(3045414) Leukocytes [Presence] in Urine
8
86
0.93
0.00
1.6
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
50
1.00
0.00
1.0
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
6
66
0.91
0.00
3.3
7.5
%
2.0
1.3
—
6
66
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_CERVIX_UTERI_EXOCERVIX_EXALLC – Carcinoma in situ of cervix uteri, exocervix
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).